ログイン 会員登録
icon_bulk_order一括注文 Acrobiosystems for English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
phone
Your Position: ホーム > MCAM

MCAM

概要

Name:Melanoma cell adhesion molecule
Target Synonym:METCAM,CD146,Melanoma cell adhesion molecule,MCAM,Cell surface glycoprotein MUC18,S-Endo 1 Endothelial-Associated Antigen,Melanoma-Associated Antigen MUC18,Melanoma-Associated Antigen A32,Gicerin,MUC18,CD146 Antigen,Cell surface glycoprotein P1H12,Melanoma Adhesion Molecule,MelCAM,HEMCAM
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase 2 Clinical

製品リスト製品比較と製品注文

ACRO Quality

生物活性データの一部

CHEK-ATP195-Cell-based assay
 MCAM FACS

Expression analysis of human MCAM on HEK293/Human MCAM Stable Cell Line by FACS.
Cell surface staining was performed on HEK293/Human MCAM Stable Cell Line or negative control cell using PE-labeled anti-human MCAM antibody.

MCM-C52H3-MALS-HPLC
Cynomolgus MCAM, His Tag (Cat. No. ) MALS images

The purity of Cynomolgus MCAM, His Tag (Cat. No. MCM-C52H3) is more than 90% and the molecular weight of this protein is around 80-90 kDa verified by SEC-MALS.

Synonym Name

MCAM,CD146,MUC18

Background

CD146, also known as the melanoma cell adhesion molecule (MCAM) or cell surface glycoprotein MUC18, is a 113kDa cell adhesion molecule currently used as a marker for endothelial cell lineage. As a member of the Immunoglobulin superfamily, It is expressed on chicken embryonic spleen and thymus, activated human T cells, endothelial progenitors such as angioblasts and mesenchymal stem cells, and strongly expressed on blood vessel endothelium and smooth muscle.CD146 has been demonstrated to appear on a small subset of T and B lymphocytes in the peripheral blood of healthy individuals. The CD146+ T cells display an immunophenotype consistent with effector memory cells and have a distinct gene profile from the CD146- T cells.As a Ca2+ independent cell adhesion molecule involved in heterophilic cell to cell interactions and a surface receptor,CD146 triggers tyrosine phosphorylation of FYN and PTK2 and subsequently induced signal transduction, proteolysis or immune recognition.

Clinical and Translational Updates

臨床試験情報

Name Research Code Research Phase Company Indications Clinical Trials
AMT-253 AMT-253 Phase 2 Clinical T-Maximum Pharmaceutical (Suzhou) Co Ltd Solid tumours; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Non-Small-Cell Lung; Melanoma Details
AMT-253 AMT-253 Phase 2 Clinical T-Maximum Pharmaceutical (Suzhou) Co Ltd Solid tumours; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Non-Small-Cell Lung; Melanoma Details

This web search service is supported by Google Inc.

totopphone